Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascletis Announces Positive Phase IIa HBV Results on Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) 2021-05-05 08:30
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products 2021-05-04 21:08
IVM-MS2, 'The Most Compact All-in-One IntraVital Two-Photon Microscopy System in the World' 2021-05-03 23:47
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study 2021-05-03 20:30
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction 2021-05-03 20:00
Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study 2021-04-30 18:00
Revotek Deploys Its Bioink Technology to Research Institutes 2021-04-29 21:30
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic 2021-04-29 20:56
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report 2021-04-29 20:30
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing 2021-04-29 19:47
Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment 2021-04-29 08:34
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration 2021-04-29 08:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
Turn Biotechnologies completes latest round of funding 2021-04-28 19:50
GenScript Launches Research-Grade Lentiviral Vector Packaging Service 2021-04-28 19:30
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi 2021-04-27 15:53
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone 2021-04-27 09:23
EpiVax Demonstrates Antigen-Specific Tolerance Induction in Allergy with Tregitopes, Results Published in Frontiers in Immunology 2021-04-27 09:00
1 321 322 323 324 325 526